FDA Clearance Tracker · P810023
COBE CENTRY(R) TPE SYSTEM
Last checked: Nov 20, 2026Latest source record: Mar 16, 1982 (this decision)Source: openFDAMethods & limitations
Decided
Mar 16, 1982
Approval withdrawn
Time to decision
302 days
Received May 18, 1981. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Unclassified
The decision
- FDA number
- P810023
- Device name
- COBE CENTRY(R) TPE SYSTEM
- Applicant
- Gambro Bct, Inc.
- Applicant location
- Lakewood, CO
- Received
- May 18, 1981
- Decided
- Mar 16, 1982
- Decision
- Approval withdrawn
- Supplements
- 1 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Unclassified
- Specialty
- GI, Urology & Nephrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code LKN (Separator, automated, blood cell and plasma, therapeutic).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Gambro Bct, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.